Agentic AI

News

Hippocratic AI builds in life sciences with Grove AI buy

Hippocratic AI has expanded with the acquisition of Grove AI, a specialist in AI used in pharma R&D, building on its patient-facing GenAI agents.

Digital

Regulators open the AI floodgates in life sciences

In 2026, biopharma will move from proving AI works to proving it can be trusted at scale.

R&D

Future glances: More change, more tech, more harmonisation

According to Deloitte’s 2026 Life Sciences Outlook Survey, the life sciences sector might be becoming increasingly borderless, but only 41% of responding biopharma and medtech executives fe

News

Man and woman AI heads - representation concept

FDA doubles down on its push into AI

The FDA has revealed the latest element in its adoption of AI, an agentic AI platform that agency staffers can use to streamline complex tasks.

Digital

From weeks to minutes: How AI transforms pharmaceutical mark...

Agentic AI isn’t just another analytical instrument. It represents a reimagining of how strategic intelligence is generated and applied.

R&D

Leveraging AI agents to eliminate ‘white space’ in clinical ...

Human-AI collaboration has the potential to mitigate gross productivity gaps and establish a new standard of clinical trial efficiency.